Summary
Corvidia Therapeutics Inc.
Founded in 2014
Description
Corvidia is now part of Novo Nordisk. Visit https://www.novonordisk-us.com/ to learn more.
Strengths
- Corvidia Therapeutics Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Corvidia Therapeutics Inc. was founded, the company has grown faster than the industry average
- Employees are staying with the company and less likely to churn compared to the rest of the industry
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
Corvidia Therapeutics Inc.'s annual revenue
$12688000
Based on Kona Equity data
-
Revenue per employee
$793000
-
Variance of revenue growth
0.17
-
Annual revenue growth since founding
$1409777
-
Revenue growth rate from first known quarter to current
785.7%
Employee Count
16 employees
-
Employee growth rate from first known quarter to current
171.4%
-
Current employees on Linkedin
18
-
Churned employees
11
-
Churn rate percentage
61.11%
Executives
Douglas Kling
Senior VP, Clinical Operations
d**@corvidiatx.comGwyn Reis
Head Senior VP, Regulatory
g**@corvidiatx.comMatt Devalaraja
Founder & Scientific Chief & Officer Head of Research & Development
m**@corvidiatx.comKurt Herzog
Senior Business Associate
k**@corvidiatx.comNatasha Uzelac
Head Director, Analytical Sciences
n**@corvidiatx.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G8 LinkedIn Churn is lower than the industry average.
Location
Unlock unlimited leads
Similar Companies
Unicycive
unicycive.com- Founded in 2016
- Location: Los Altos, CA
- Annual Revenue: $3.0M
- Employees: 9
- Unicycive Therapeutics (UNCY) invents and develop medications that make a meaningful difference in the lives of kidney patients and their caregivers. Unicycive Therapeutics invent and develop medications that help kidney patients feel their best and en...
Better Therapeutics
getbetter.io- Location: San Francisco, CA
- Annual Revenue: $2.0M
- Employees: 32
- Better Therapeutics discovers, develops and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases.
Aqualung Therapeutics
aqualungtherapeutics.com- Founded in 2010
- Location: Chicago, IL
- Annual Revenue: $1.3M
- Employees: 6
- Aqualung Therapeutics Corp. is an early stage biotech company developing a therapeutic antibody to reduce inflammation in acute and chronic lung diseases. Aqualung Therapeutics (ALT) is developing multi-pronged strategies to address the development of ...
Kramann Laboratory
kramannlab.com- Annual Revenue: $2.5M
- Employees: 13
- Kramann Lab is a research lab focused on translational cardiovascular and kidney research, with a specific focus on solid organ fibrosis and cardiovascular disease in chronic kidney disease.
pyrosequencing.ws
pyrosequencing.ws- Location: Shallowater, TX
- Annual Revenue: $2.3M
- Employees: 11
Molecular Research Center
qiime.com- Founded in 2011
- Location: Cincinnati, OH
- Annual Revenue: $1.8M
- Employees: 9
Key Information
- Name: Corvidia Therapeutics Inc.
- Category: Pharmaceuticals
- Industry: Corporate Office
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City Waltham Small Corporate Office in Waltham Mid-size Corporate Office in Waltham Pharmaceuticals in Waltham Small Pharmaceuticals in Waltham Mid-size Pharmaceuticals in Waltham
-
By State MA Small companies in MA Pharmaceuticals in MA Small Pharmaceuticals in MA Mid-size Pharmaceuticals in MA Small Corporate Office in MA Mid-size Corporate Office in MA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Corporate Office Small Corporate Office Mid-size Corporate Office Pharmaceuticals and Corporate Office
-
Firmographic data G Score of 6 Founded in 2014 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Business Services General #Business Services
Frequently Asked Questions
Corvidia Therapeutics Inc.'s headquarters are located at 35 Gatehouse Dr. Waltham, MA 02451.
Corvidia Therapeutics Inc.'s official website is corvidiatx.com
Corvidia Therapeutics Inc.'s annual revenue is $12.7 M.
Corvidia Therapeutics Inc.'s SIC: 87; 873
Corvidia Therapeutics Inc.'s NAICS: 5417; 541.
Corvidia Therapeutics Inc. has 16 employees
Corvidia Therapeutics Inc. is in the industry of Pharmaceuticals.
